Aetna Stock Price, News & Analysis (NYSE:AET)

$173.20 -1.56 (-0.89 %)
(As of 11/17/2017 08:00 AM ET)
Previous Close$174.76
Today's Range$172.99 - $175.30
52-Week Range$116.04 - $184.98
Volume1.75 million shs
Average Volume2.43 million shs
Market Capitalization$56.99 billion
P/E Ratio16.83
Dividend Yield1.17%
Beta0.61

About Aetna (NYSE:AET)

Aetna logoAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers' compensation administrative services and health information technology (HIT) products and services. The Health Care segment consists of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an Insured basis and an employer-funded basis, and emerging businesses products and services. The Group Insurance segment includes group life insurance and group disability products. Its products are offered on an Insured basis.


Industry, Sector and Symbol:
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Sector: Managed Health Care - NEC
  • Symbol: NYSE:AET
  • CUSIP: 00817Y10
  • Web: www.aetna.com
Debt:
  • Debt-to-Equity Ratio: 0.52%
  • Current Ratio: 0.53%
  • Quick Ratio: 0.53%
Price-To-Earnings:
  • Trailing P/E Ratio: 16.83
  • Forward P/E Ratio: 17.71
  • P/E Growth: 1.57
Sales & Book Value:
  • Annual Sales: $63.155 billion
  • Price / Sales: 0.89
  • Cash Flow: $10.54 per share
  • Price / Cash: 16.44
  • Book Value: $48.51 per share
  • Price / Book: 3.57
Dividend:
  • Annual Dividend: $2.00
  • Dividend Yield: 1.2%
Profitability:
  • Trailing EPS: $5.41
  • Net Income: $2.271 billion
  • Net Margins: 2.93%
  • Return on Equity: 21.84%
  • Return on Assets: 5.80%
Misc:
  • Employees: 49,500
  • Outstanding Shares: 326,100,000
 

Frequently Asked Questions for Aetna (NYSE:AET)

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna declared a quarterly dividend on Friday, September 29th. Investors of record on Thursday, October 12th will be given a dividend of $0.50 per share on Friday, October 27th. This represents a $2.00 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Wednesday, October 11th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna announced that its board has approved a stock repurchase plan on Friday, April 7th 2017, which allows the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 98% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna Inc. (NYSE:AET) issued its earnings results on Tuesday, October, 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business's revenue for the quarter was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.07 earnings per share. View Aetna's Earnings History.

When will Aetna make its next earnings announcement?

Aetna is scheduled to release their next quarterly earnings announcement on Tuesday, January, 30th 2018. View Earnings Estimates for Aetna.

What guidance has Aetna issued on next quarter's earnings?

Aetna issued an update on its FY17 earnings guidance on Tuesday, October, 31st. The company provided earnings per share guidance of ~$9.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.56.

Where is Aetna's stock going? Where will Aetna's stock price be in 2017?

20 Wall Street analysts have issued 1-year price objectives for Aetna's stock. Their predictions range from $135.00 to $200.00. On average, they anticipate Aetna's share price to reach $175.56 in the next twelve months. View Analyst Ratings for Aetna.

What are Wall Street analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:

  • 1. According to Zacks Investment Research, "Aetna’s third-quarter earnings surpassed the Zacks Consensus Estimate and grew year over year, driven by strong underwriting margin performance, disciplined pricing, a focus on high quality care management, and a decline in medical cost. Aetna’s shares have outperformed the industry year to date. We expect the company to witness long-term growth from its Government business and International expansion. Its cost-reduction initiatives will aid margins. The sale of its Group Life and Disability business will help it to focus on core growth areas. Following strong third-quarter results, Aetna raised its earnings guidance, cementing investors' confidence in it. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (11/2/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank Of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
  • 4. Oppenheimer Holdings, Inc. analysts commented, "Overall, we believe Humana is well positioned for growth, given the political support in Washington, ample strategic capital to deploy and the potential for upside to its current earnings base."Ultimately, this will also remain a desirable asset that could be acquired by another insurer." (3/31/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:

  • Mark T. Bertolini, Chairman of the Board, Chief Executive Officer (Age 60)
  • Karen S. Lynch, President (Age 54)
  • Shawn M. Guertin, Chief Financial Officer, Executive Vice President, Chief Enterprise Risk Officer (Age 53)
  • Thomas J. Sabatino Jr., Executive Vice President, General Counsel (Age 58)
  • Gary W. Loveman Ph.D., Executive Vice President - Consumer and Health Services (Age 56)
  • Margaret M. McCarthy, Executive Vice President - Operations and Technology (Age 63)
  • Harold L. Paz M.D., Executive Vice President, Chief Medical Officer (Age 62)
  • Francis S. Soistman Jr., Executive Vice President - Government Services (Age 60)
  • Heather Dixon, Chief Accounting Officer, Vice President, Controller (Age 45)
  • Edward J. Ludwig, Lead Independent Director (Age 65)

Who owns Aetna stock?

Aetna's stock is owned by many different of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (1.35%), Bank of New York Mellon Corp (1.31%), Davis Selected Advisers (1.17%), Dimensional Fund Advisors LP (1.13%), Ameriprise Financial Inc. (0.73%) and Legal & General Group Plc (0.56%). Company insiders that own Aetna stock include Francis S Soistman Jr, Gary W Loveman, Jeffrey E Garten, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini, Molly Joel Coye and Shawn M Guertin. View Institutional Ownership Trends for Aetna.

Who sold Aetna stock? Who is selling Aetna stock?

Aetna's stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., Capital International Investors, APG Asset Management N.V., Principal Financial Group Inc., Davis Selected Advisers, Dimensional Fund Advisors LP, State of Tennessee Treasury Department and Cohen & Steers Inc.. Company insiders that have sold Aetna company stock in the last year include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Insider Buying and Selling for Aetna.

Who bought Aetna stock? Who is buying Aetna stock?

Aetna's stock was acquired by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Point72 Asset Management L.P., Ardevora Asset Management LLP, Stifel Financial Corp, KBC Group NV, Caisse DE Depot ET Placement DU Quebec, Canada Pension Plan Investment Board and New York State Common Retirement Fund. View Insider Buying and Selling for Aetna.

How do I buy Aetna stock?

Shares of Aetna can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of Aetna stock can currently be purchased for approximately $173.20.

How big of a company is Aetna?

Aetna has a market capitalization of $56.99 billion and generates $63.155 billion in revenue each year. The company earns $2.271 billion in net income (profit) each year or $5.41 on an earnings per share basis. Aetna employs 49,500 workers across the globe.

How can I contact Aetna?

Aetna's mailing address is 151 Farmington Ave, HARTFORD, CT 06156-0001, United States. The company can be reached via phone at +1-860-2730123 or via email at [email protected]


MarketBeat Community Rating for Aetna (NYSE AET)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  670 (Vote Outperform)
Underperform Votes:  433 (Vote Underperform)
Total Votes:  1,103
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Aetna (NYSE:AET)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 8 Hold Ratings, 12 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $175.56 (1.36% upside)

Consensus Price Target History for Aetna (NYSE:AET)

Price Target History for Aetna (NYSE:AET)

Analysts' Ratings History for Aetna (NYSE:AET)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Piper Jaffray CompaniesReiterated RatingHold$187.00N/AView Rating Details
11/3/2017Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$200.00N/AView Rating Details
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$174.00N/AView Rating Details
11/2/2017Citigroup Inc.Boost Price TargetBuy$183.00 -> $197.00N/AView Rating Details
11/1/2017Jefferies Group LLCBoost Price TargetHold$165.00 -> $185.00N/AView Rating Details
10/27/2017BMO Capital MarketsBoost Price TargetMarket Perform$175.00 -> $200.00N/AView Rating Details
10/26/2017Cantor FitzgeraldDowngradeOverweight -> NeutralN/AView Rating Details
9/12/2017ArgusReiterated RatingBuy$165.00 -> $185.00LowView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$172.00 -> $179.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetHold$157.00 -> $163.00LowView Rating Details
8/4/2017Royal Bank Of CanadaBoost Price TargetOutperform -> Outperform$162.00 -> $171.00MediumView Rating Details
5/27/2017Cowen and CompanySet Price TargetBuy$145.00 -> $170.00N/AView Rating Details
5/17/2017Bank of America CorporationReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017Barclays PLCReiterated RatingOverweight$162.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
6/2/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
2/2/2016WedbushLower Price TargetNeutral$130.00 -> $120.00N/AView Rating Details
(Data available from 11/18/2015 forward)

Earnings

Earnings History and Estimates Chart for Aetna (NYSE:AET)

Earnings by Quarter for Aetna (NYSE:AET)

Earnings History by Quarter for Aetna (NYSE AET)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/29/2018N/AView Earnings Details
10/31/2017Q3 2017$2.06$2.45$15.12 billion$14.99 billionViewN/AView Earnings Details
8/3/2017Q2 2017$2.34$3.42$15.34 billion$15.52 billionViewListenView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.39 billion$15.17 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aetna (NYSE:AET)
2017 EPS Consensus Estimate: $8.20
2018 EPS Consensus Estimate: $9.95
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.29$2.40$2.33
Q2 20174$2.30$2.38$2.35
Q3 20174$2.08$2.42$2.17
Q4 20174$1.15$1.74$1.35
Q1 20181$2.75$2.75$2.75
Q2 20182$2.62$2.82$2.72
Q3 20182$2.60$2.67$2.64
Q4 20181$1.84$1.84$1.84
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Aetna (NYSE:AET)

Most Recent Dividend:10/27/2017
Annual Dividend:$2.00
Dividend Yield:1.15%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:36.97% (Trailing 12 Months of Earnings)
20.45% (Based on This Year's Estimates)
19.74% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Aetna (NYSE:AET)

Dividend History by Quarter for Aetna (NYSE AET)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/29/2017quarterly$0.501.25%10/11/201710/12/201710/27/2017
5/19/2017quarterly$0.501.42%7/11/20177/13/20177/28/2017
2/17/2017quarterly$0.501.58%4/11/20174/13/20174/28/2017
12/2/2016quarterly$0.250.77%1/10/20171/12/20171/27/2017
9/30/2016quarterly$0.250.87%10/11/201610/13/201610/28/2016
5/20/2016quarterly$0.250.91%7/12/20167/14/20167/29/2016
2/19/2016quarterly$0.250.94%4/12/20164/14/20164/29/2016
12/4/2015quarterly$0.250.97%1/12/20161/14/20161/29/2016
9/25/2015quarterly$0.250.95%10/13/201510/15/201510/30/2015
5/15/2015quarterly$0.250.88%7/14/20157/16/20157/31/2015
2/27/2015quarterly$0.251%4/7/20154/9/20154/24/2015
11/21/2014quarterly$0.251.15%1/13/20151/15/20151/30/2015
9/19/2014quarterly$0.231.08%10/14/201410/16/201410/31/2014
5/30/2014quarterly$0.231.16%7/8/20147/10/20147/25/2014
2/28/2014quarterly$0.231.25%4/8/20144/10/20144/25/2014
12/6/2013quarterly$0.231.35%1/14/20141/16/20141/31/2014
9/27/2013quarterly$0.201.25%10/8/201310/10/201310/25/2013
5/17/2013quarterly$0.201.35%7/9/20136/11/20137/26/2013
2/19/2013quarterly$0.201.66%4/9/20134/11/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aetna (NYSE AET)

Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 90.93%
Insider Trades by Quarter for Aetna (NYSE:AET)
Insider Trades by Quarter for Aetna (NYSE:AET)

Insider Trades by Quarter for Aetna (NYSE AET)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2017Karen S LynchPresidentSell15,271$161.91$2,472,527.61View SEC Filing  
9/15/2017Margaret M MccarthyEVPSell10,288$162.85$1,675,400.80View SEC Filing  
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.44View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.70View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.86View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.88View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.05View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.50View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.00View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.81View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.00View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.75View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.70View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Aetna (NYSE:AET)

Latest Headlines for Aetna (NYSE AET)

Source:
DateHeadline
Exceptional Earnings Growth Analytics Drive Upgrade of Aetna (AET) to Strong Buy - Investorplace.comExceptional Earnings Growth Analytics Drive Upgrade of Aetna (AET) to Strong Buy - Investorplace.com
investorplace.com - November 16 at 10:48 AM
Lightning Round: Jim Cramer Weighs In On Wendys, Aetna And ... - BenzingaLightning Round: Jim Cramer Weighs In On Wendys, Aetna And ... - Benzinga
www.benzinga.com - November 16 at 10:48 AM
Exceptional Earnings Growth Analytics Drive Upgrade of Aetna (AET) to Strong BuyExceptional Earnings Growth Analytics Drive Upgrade of Aetna (AET) to Strong Buy
investorplace.com - November 15 at 11:01 AM
CVS Short Sellers Ready to Reload PositionsCVS Short Sellers Ready to Reload Positions
finance.yahoo.com - November 14 at 4:02 PM
Needham Sees A Healthy Risk-Reward For CVS Health - BenzingaNeedham Sees A Healthy Risk-Reward For CVS Health - Benzinga
www.benzinga.com - November 10 at 4:07 PM
Trade of the Day: Aetna Inc (AET) - Investorplace.comTrade of the Day: Aetna Inc (AET) - Investorplace.com
investorplace.com - November 10 at 4:07 PM
Needham Sees A Healthy Risk-Reward For CVS HealthNeedham Sees A Healthy Risk-Reward For CVS Health
finance.yahoo.com - November 10 at 4:07 PM
Trade of the Day: Aetna Inc (AET)Trade of the Day: Aetna Inc (AET)
investorplace.com - November 10 at 9:27 AM
Obamacare first-day signups more than double last years - Seeking AlphaObamacare first-day signups more than double last year's - Seeking Alpha
seekingalpha.com - November 9 at 9:35 PM
ETFs with exposure to Aetna, Inc. : November 9, 2017ETFs with exposure to Aetna, Inc. : November 9, 2017
finance.yahoo.com - November 9 at 4:32 PM
Stock of Aetna (AET) Upgraded to Strong Buy From a Buy - Investorplace.comStock of Aetna (AET) Upgraded to Strong Buy From a Buy - Investorplace.com
investorplace.com - November 9 at 3:37 AM
Richard Pzena Buys Mylan NV, Hewlett Packard Enterprise Co, Wells Fargo, Sells Staples Inc, ...Richard Pzena Buys Mylan NV, Hewlett Packard Enterprise Co, Wells Fargo, Sells Staples Inc, ...
www.nasdaq.com - November 8 at 10:36 PM
Aetna Introduces New Low-Cost Prescription Drug Plan (PDP)Aetna Introduces New Low-Cost Prescription Drug Plan (PDP)
finance.yahoo.com - November 8 at 10:36 PM
CBO lowers estimated deficit reduction impact from repeal of ACA - Seeking AlphaCBO lowers estimated deficit reduction impact from repeal of ACA - Seeking Alpha
seekingalpha.com - November 8 at 5:32 PM
5 Things CVS Health's Management Just Said That You'll Want to Know5 Things CVS Health's Management Just Said That You'll Want to Know
finance.yahoo.com - November 8 at 5:32 PM
How You Might Be Eligible for a Free Apple Watch From Your Health InsurerHow You Might Be Eligible for a Free Apple Watch From Your Health Insurer
finance.yahoo.com - November 8 at 5:32 PM
Aetna, Inc. :AET-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017Aetna, Inc. :AET-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017
finance.yahoo.com - November 8 at 5:32 PM
Stock of Aetna (AET) Upgraded to Strong Buy From a BuyStock of Aetna (AET) Upgraded to Strong Buy From a Buy
investorplace.com - November 8 at 12:24 PM
Aetna Inc. (AET) Expected to Post Quarterly Sales of $14.91 BillionAetna Inc. (AET) Expected to Post Quarterly Sales of $14.91 Billion
www.americanbankingnews.com - November 8 at 2:30 AM
CVS Is Preparing for the Amazon InvasionCVS Is Preparing for the Amazon Invasion
finance.yahoo.com - November 7 at 5:10 PM
Aetna Inc. (AET) Expected to Announce Earnings of $1.24 Per ShareAetna Inc. (AET) Expected to Announce Earnings of $1.24 Per Share
www.americanbankingnews.com - November 6 at 11:26 PM
Anthem top executive Swedish to become adviser, Boudreaux named CEO - ReutersAnthem top executive Swedish to become adviser, Boudreaux named CEO - Reuters
www.reuters.com - November 6 at 9:21 PM
CVS Healths profit drops 17 pctCVS Health's profit drops 17 pct
finance.yahoo.com - November 6 at 4:18 PM
CVS Posts Negative Retail Same-Store Sales, Announces Next-Day DeliveryCVS Posts Negative Retail Same-Store Sales, Announces Next-Day Delivery
finance.yahoo.com - November 6 at 4:18 PM
Why Amazon Should Buy CVS HealthWhy Amazon Should Buy CVS Health
finance.yahoo.com - November 6 at 4:18 PM
[$$] CVS, With an Eye on Amazon, to Launch Next-Day Delivery[$$] CVS, With an Eye on Amazon, to Launch Next-Day Delivery
finance.yahoo.com - November 6 at 4:18 PM
CVS to start next-day delivery as Amazon threat loomsCVS to start next-day delivery as Amazon threat looms
finance.yahoo.com - November 6 at 4:18 PM
CVS Announces Same-Day Delivery To Fight Off AmazonCVS Announces Same-Day Delivery To Fight Off Amazon
finance.yahoo.com - November 6 at 4:18 PM
CVS beats earnings expectations amid potential Aetna tie-upCVS beats earnings expectations amid potential Aetna tie-up
www.cnbc.com - November 6 at 7:56 AM
Catamaran Corp (USA) (SXCI) versus Aetna (AET) Head-To-Head SurveyCatamaran Corp (USA) (SXCI) versus Aetna (AET) Head-To-Head Survey
www.americanbankingnews.com - November 5 at 3:26 AM
CVS, Aetna aim to finalize deal by DecemberCVS, Aetna aim to finalize deal by December
finance.yahoo.com - November 4 at 5:04 PM
Aetna stock spikes after report that CVS deal could be finalized by DecemberAetna stock spikes after report that CVS deal could be finalized by December
finance.yahoo.com - November 4 at 5:04 PM
Aetna Gains on Report That CVS Deal Price Could Top $70 BillionAetna Gains on Report That CVS Deal Price Could Top $70 Billion
finance.yahoo.com - November 4 at 5:04 PM
CVS-Aetna Deal Could Come as Soon as December: ReportCVS-Aetna Deal Could Come as Soon as December: Report
finance.yahoo.com - November 4 at 5:04 PM
Aetna Soars As CVS Health Deal Offer Could Top $70 BillionAetna Soars As CVS Health Deal Offer Could Top $70 Billion
finance.yahoo.com - November 4 at 5:04 PM
Why CVS Health Crashed 15.7% in OctoberWhy CVS Health Crashed 15.7% in October
finance.yahoo.com - November 4 at 5:04 PM
Aetna Inc. (AET) Earns Hold Rating from Piper Jaffray CompaniesAetna Inc. (AET) Earns Hold Rating from Piper Jaffray Companies
www.americanbankingnews.com - November 3 at 10:46 PM
The $70 billion deal between CVS and Aetna could be finalized by next month - Business InsiderThe $70 billion deal between CVS and Aetna could be finalized by next month - Business Insider
www.businessinsider.com - November 3 at 8:29 PM
CVS, Aetna aim to finalize deal as early as December: ReportCVS, Aetna aim to finalize deal as early as December: Report
www.cnbc.com - November 3 at 3:56 PM
CVS/Aetna hope to seal deal as soon as December - ReutersCVS/Aetna hope to seal deal as soon as December - Reuters
seekingalpha.com - November 3 at 3:38 PM
LPC: US healthcare brightens tame US high-grade M&A lendingLPC: US healthcare brightens tame US high-grade M&A lending
finance.yahoo.com - November 3 at 3:27 PM
CVS, Aetna aim to finalize deal as early as December: sourcesCVS, Aetna aim to finalize deal as early as December: sources
finance.yahoo.com - November 3 at 3:27 PM
Top Analyst Upgrades and Downgrades: Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter, YogaWorks and MoreTop Analyst Upgrades and Downgrades: Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter, YogaWorks and More
www.marketwatch.com - November 3 at 10:11 AM
The Zacks Analyst Blog Highlights: Citigroup, Qualcomm, Aetna, Honda and Electronic ArtsThe Zacks Analyst Blog Highlights: Citigroup, Qualcomm, Aetna, Honda and Electronic Arts
finance.yahoo.com - November 3 at 10:11 AM
Raymond James Financial, Inc. Upgrades Aetna Inc. (AET) to OutperformRaymond James Financial, Inc. Upgrades Aetna Inc. (AET) to Outperform
www.americanbankingnews.com - November 3 at 10:02 AM
Aetna Inc. (AET) Now Covered by Analysts at Credit Suisse Group AGAetna Inc. (AET) Now Covered by Analysts at Credit Suisse Group AG
www.americanbankingnews.com - November 2 at 8:33 PM
Aetna silent on CVS bid reports, flags tax hit in 2018 - ReutersAetna silent on CVS bid reports, flags tax hit in 2018 - Reuters
www.reuters.com - November 2 at 3:38 PM
Here's Why Constellation Brands Is Cozying Up to CannabisHere's Why Constellation Brands Is Cozying Up to Cannabis
finance.yahoo.com - November 2 at 3:38 PM
Aetna (AET) vs. Its Rivals Financial ComparisonAetna (AET) vs. Its Rivals Financial Comparison
www.americanbankingnews.com - November 2 at 3:18 PM
Aetna Inc. to Post Q1 2018 Earnings of $2.75 Per Share, Oppenheimer Holdings Forecasts (AET)Aetna Inc. to Post Q1 2018 Earnings of $2.75 Per Share, Oppenheimer Holdings Forecasts (AET)
www.americanbankingnews.com - November 2 at 1:38 PM

Social Media

Financials

Chart

Aetna (NYSE AET) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.